TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100. A total of 44 filers reported holding TRANSPHORM INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $491,656 | -34.0% | 221,467 | +1.1% | 0.00% | – |
| Q2 2023 | $744,773 | -1.2% | 219,051 | +15.9% | 0.00% | – |
| Q1 2023 | $754,098 | -24.3% | 188,997 | +3.2% | 0.00% | – |
| Q4 2022 | $996,646 | +8.0% | 183,207 | -0.2% | 0.00% | – |
| Q3 2022 | $923,000 | +39.0% | 183,616 | +5.4% | 0.00% | – |
| Q2 2022 | $664,000 | – | 174,129 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 3,772,875 | $18,978,000 | 5.90% |
| Worth Venture Partners, LLC | 911,237 | $4,584,000 | 2.81% |
| Kohlberg Kravis Roberts & Co. L.P. | 22,675,980 | $114,060,000 | 2.29% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 250,944 | $1,262,000 | 1.37% |
| Soros Fund Management | 673,991 | $3,390,000 | 0.06% |
| Polar Asset Management Partners Inc. | 709,700 | $3,570,000 | 0.04% |
| AMERIPRISE FINANCIAL INC | 3,805,595 | $19,142,000 | 0.01% |
| Stratos Wealth Partners, LTD. | 30,000 | $151,000 | 0.00% |
| FMR LLC | 886 | $4,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 10,801 | $54,000 | 0.00% |